ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,173.02
0.64%
Dow Jones
42,544.22
-0.07%
Gold vs US Dollar
2,622.83
-0.06%
Brent Oil
73.855
-1.33%
Bitcoin
94,430.06
1.12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clearside Biomedical Inc (CLSD) Share Price

CLSD Clearside Biomedical Inc

0.9799
-0.0149 (-1.50%)
01 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Clearside Biomedical Inc NASDAQ:CLSD NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0149 -1.50 0.9799 0.79 1.04 1.00 0.94 1 316,582 05:00:01   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 8.23M -32.49M -0.4283 -2.22 75.45M
 Type  Size  Price  Time  Units 
 9 8 0.98 00:08:24 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CLSD News
19/12/202412:05GLOBEClearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye
25/11/202412:05GLOBEClearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
12/11/202421:10EDGAR2Form 8-K - Current report
12/11/202421:05GLOBEClearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
07/11/202414:05GLOBEClearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
06/11/202412:05GLOBEClearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
04/11/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for CLSD

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Clearside Biomedical Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads